Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

October 15, 2021

Conditions
MigraineHeadache Disorders, Primary
Interventions
OTHER

Ultrasound guided greater occipital nerve (GON) radiofrequency

After identifying the GON with ultrasound guidance, a catheter needle (22-gauge 5 cm 5 mm active tip hybrid electrode) is inserted with an in-plane technique from lateral to medial.After visualizing the electrode tip placed close to the right or left GON, a sensory stimulation test is performed using an RF generator (URF-3AP Diros Tecnology Inc.). After the patient reports dysesthesia and a tingling sensation at the occipital area with less than 0.2 V, the PRF treatment is administered at 5 Hz and 5 milliseconds pulsed width for 360 seconds at 45 V under the constraint that the temperature of the electrode tips does not exceed 42°C

Trial Locations (1)

35000

Tepecik Training and Research Hospital, Izmir

All Listed Sponsors
lead

Tepecik Training and Research Hospital

OTHER

NCT05199064 - Efficacy of Greater Occipital Nerve Radiofrequency for Refractory Migraine Treatment | Biotech Hunter | Biotech Hunter